Work

Fixed-dose inotuzumab ozogamicin combined with vincristine and prednisone regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-1554

Authors: Lei Ju, Guixi Liu, Jilei Zhang, Yuyu Liu, Lin Dong, Yan Guo, Xuemei Qin, Qiang Song, Jie Zou, Chenglu Yuan, Yan Shi, Dexiao Kong, Sifeng Gao, Yingchang Mi, Qingliang Teng, Jun Peng, Guanchen Bai

Institutions: Qingdao University, Taian City Central Hospital, Shandong First Medical University, Qilu Hospital of Shandong University, Shandong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417011776

Cites:

Cited by: 1

Related to: